{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:14:16Z","timestamp":1790957656262,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Australian Better Health Initiative"},{"name":"Royal Perth Hospital"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ijcard.2015.08.146","type":"journal-article","created":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T22:42:56Z","timestamp":1440196976000},"page":"633-638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia"],"prefix":"10.1016","volume":"201","author":[{"given":"Dick C.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damon A.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"van Bockxmeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2015.08.146_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2863","article-title":"Familial hypercholesterolemia","author":"Goldstein","year":"2001"},{"key":"10.1016\/j.ijcard.2015.08.146_bb0010","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ncpcardio0836","article-title":"Mechanisms of disease: genetic causes of familial hypercholesterolemia","volume":"4","author":"Soutar","year":"2007","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0015","series-title":"Report of a Second WHO Consultation","article-title":"Familial hypercholesterolaemia","author":"World Health Organization","year":"1999"},{"key":"10.1016\/j.ijcard.2015.08.146_bb0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1469-1809.2008.00436.x","article-title":"Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database","volume":"72","author":"Leigh","year":"2008","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0021-9150(99)00336-6","article-title":"Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia","volume":"149","author":"Sijbrands","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2015.08.146_bb0030","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/hrt.2003.022764","article-title":"Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia","volume":"90","author":"Neil","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2015.08.146_bb0035","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/01.ATV.11.2.290","article-title":"Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia","volume":"11","author":"Hill","year":"1991","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0040","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2796.2004.01405.x","article-title":"The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients","volume":"256","author":"Jansen","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2796.2003.01070.x","article-title":"Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia","volume":"253","author":"De Sauvage Nolting","year":"2003","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0050","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2007.12.024","article-title":"Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors","volume":"200","author":"Alonso","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2015.08.146_bb0055","first-page":"808353","article-title":"Pathophysiology of vascular remodeling in hypertension","volume":"2013","author":"Renna","year":"2013","journal-title":"Int. J. Hypertens."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0060","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/01.HYP.0000198544.09909.1a","article-title":"Adult hypertension and kidney disease: the role of fetal programming","volume":"47","author":"Zandi-Nejad","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2015.08.146_bb0065","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/sj.ki.5002131","article-title":"In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients","volume":"71","author":"Frischmann","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0070","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1523-1755.2005.00551.x","article-title":"Cardiovascular and renal progression factors in chronic kidney disease","volume":"68","author":"Menon","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0735-1097(02)02663-3","article-title":"Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community","volume":"41","author":"Manjunath","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0080","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0085","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2796.2012.02592.x","article-title":"Lipoprotein(a): resurrected by genetics","volume":"273","author":"Kronenberg","year":"2013","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/MOL.0000000000000096","article-title":"Lipoprotein(a): gene genie","volume":"25","author":"Durrington","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0095","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9149(00)01429-6","article-title":"Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia","volume":"87","author":"Hopkins","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0100","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) levels in familial hypercholesterolaemia: an important predictor for cardiovascular disease independent of the type of LDL-receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1476-511X-13-65","article-title":"Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort","volume":"13","author":"Allard","year":"2014","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0110","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/0140-6736(90)91242-3","article-title":"Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia","volume":"335","author":"Wiklund","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2015.08.146_bb0115","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1172\/JCI117292","article-title":"The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate","volume":"93","author":"Rader","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00041433-200404000-00009","article-title":"Structure\u2013function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity","volume":"15","author":"Koschinsky","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0125","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.atherosclerosis.2012.07.030","article-title":"Genetic analysis of familial hypercholesterolaemia in Western Australia","volume":"224","author":"Hooper","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2015.08.146_bb0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2014.12.036","article-title":"Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience","volume":"239","author":"Bell","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2015.08.146_bb0135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.atherosclerosis.2015.03.003","article-title":"Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales","volume":"240","author":"Haralambos","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2015.08.146_bb0140","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9149(03)00530-7","article-title":"Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)","volume":"92","author":"Jones","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0150","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5694\/mja11.11468","article-title":"Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement","volume":"197","author":"Johnson","year":"2012","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0155","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.atherosclerosis.2013.12.028","article-title":"Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia","volume":"233","author":"Caleb","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2015.08.146_bb0160","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/nar\/25.1.172","article-title":"Software and database for the analysis of mutations in the human LDL receptor gene","volume":"25","author":"Varret","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0165","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev.ge.24.120190.001025","article-title":"The LDL receptor in familial hypercholesterolemia: mutational analysis of a membrane protein","volume":"24","author":"Hobbs","year":"1990","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0170","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/01.CIR.92.3.290","article-title":"Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation","volume":"92","author":"Ferri\u00e8res","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.08.146_bb0175","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.atherosclerosis.2011.02.007","article-title":"Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia","volume":"216","author":"Nenseter","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2015.08.146_bb0180","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/archinte.160.8.1093","article-title":"The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus","volume":"160","author":"Valmadrid","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0021-9150(99)00064-7","article-title":"Atherogenicity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux","volume":"143","author":"Nielsen","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2015.08.146_bb0190","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/j.1538-7836.2008.03183.x","article-title":"Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation","volume":"6","author":"Feric","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0195","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.ATV.0000280571.28102.d4","article-title":"New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease","volume":"27","author":"Tsimikas","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0200","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa043175","article-title":"Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease","volume":"353","author":"Tsimikas","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0205","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/01.ATV.11.4.940","article-title":"Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolaemia, their relatives and matched control populations","volume":"11","author":"Mbewu","year":"1991","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.ijcard.2015.08.146_bb0210","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0022-2275(20)41918-2","article-title":"Diverse effect of ethnicity on plasma lipoprotein[a] levels in heterozygote patients with familial hypercholesterolemia","volume":"32","author":"Leitersdorf","year":"1991","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0009-9120(02)00416-2","article-title":"Evaluation of a fully-automated particle-enhanced turbidimetric immunoassay for the measurement of plasma lipoprotein(a). Population-based reference values in an area with low incidence of cardiovascular disease","volume":"36","author":"Sim\u00f3","year":"2003","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0220","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/joim.12187","article-title":"Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease","volume":"276","author":"Hopewell","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0225","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/eurheartj\/ehq208","article-title":"A frequent variant in the ABCA1 gene is associated with increased coronary heart disease risk and a better response to statin treatment in familial hypercholesterolemia patients","volume":"32","author":"Versmissen","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.08.146_bb0230","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00109-010-0624-3","article-title":"Telomeres are shorter in myocardial infarction patients compared to healthy subjects: correlation with environmental risk factors","volume":"88","author":"Maubaret","year":"2010","journal-title":"J. Mol. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315303740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315303740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T19:59:38Z","timestamp":1653076778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315303740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":46,"alternative-id":["S0167527315303740"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.08.146","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.08.146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}